117th Congress · HOUSE BILLBILL

H.R. 6710To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.

To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to submit to Congress a report on barriers, including regulatory inefficiencies, to domestic manufacturing of active pharmaceutical ingredients, finished drug products, and devices, and for other purposes.

Health
Introduced Feb 11, 2022
Last action Feb 14, 2022
Pipeline · Bill → Law
Step 1
Introduced
Feb 11, 2022
Step 2
Referred
Feb 14, 2022
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryNo summary available

No CRS summary available for this bill.

Provisions · 1 sectionsIntroduced in House
Timeline · 3 actions
Feb 14, 2022
Referred to the Subcommittee on Health.
Feb 11, 2022
Introduced in House
Feb 11, 2022
Referred to the House Committee on Energy and Commerce.